Zobrazeno 1 - 10
of 177
pro vyhledávání: '"O Kloke"'
Publikováno v:
DMW - Deutsche Medizinische Wochenschrift. 111:767-772
Interferon (IFN-alpha 2 B) was administered to 21 patients with chronic myeloid leukaemia (CML), at an initial dose of 4 X 10(6) IU/m2 daily subcutaneously, adapted to changes in leukocyte count in the course of treatment. Of 16 patients that could b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cacb1b369ae9b4281b8dbe330d27ebe6
https://doi.org/10.1055/s-2008-1068529
https://doi.org/10.1055/s-2008-1068529
Publikováno v:
Supportive Care in Cancer. 8:479-486
The charts of 273 cancer patients were retrospectively analyzed in order (1) to evaluate the frequency of opioid change (OCH) when adjuvants (antiemetics/laxatives) were administered on a regular basis and co-analgesic medication as indicated by the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::75f2e5eff6b4525e236817bcc1cd68ab
https://doi.org/10.1007/s005200000153
https://doi.org/10.1007/s005200000153
Autor:
O. Kloke
Publikováno v:
Zeitschrift f�r Gerontologie und Geriatrie. 34:277-279
Mit zunehmendem Alter steigt die Inzidenz von Bronchialkarzinomen stetig an, wobei bei alten Menschen die nichtkleinzelligen Karzinome deutlich uberwiegen. Gemas den Daten multizentrischer Studien zur Chemotherapie nichtkleinzelliger Bronchialkarzino
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1e3a3782a7836fed99f8cc8db6d77616
https://doi.org/10.1007/s003910170051
https://doi.org/10.1007/s003910170051
Publikováno v:
Therapiekonzepte Onkologie ISBN: 9783540285885
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::31868d55504d1b68f8c5a010d7575617
https://doi.org/10.1007/978-3-540-28978-4_68
https://doi.org/10.1007/978-3-540-28978-4_68
Publikováno v:
Laryngo-Rhino-Otologie. 77:82-84
Background Carboplatin is regarded as a non-ototoxic or low-grade ototoxic chemotherapeutic agent. Method We report on three patients with a recurrence of testicular cancer after cisplatin chemotherapy who suffered hearing loss after subsequent high-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4241166644f5b1cbc3fa7f9491d5fa96
https://doi.org/10.1055/s-2007-996937
https://doi.org/10.1055/s-2007-996937
Publikováno v:
Annals of oncology : official journal of the European Society for Medical Oncology. 16
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9ece5e60568ad111211377d8698c7023
https://pubmed.ncbi.nlm.nih.gov/15888764
https://pubmed.ncbi.nlm.nih.gov/15888764
Publikováno v:
Annals of oncology : official journal of the European Society for Medical Oncology. 16
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5d3c76e963722d599adbf2d54b6d2802
https://pubmed.ncbi.nlm.nih.gov/15888750
https://pubmed.ncbi.nlm.nih.gov/15888750
Publikováno v:
Zeitschrift für Palliativmedizin. 6
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::94ff39db735d0a01b87dcbcd7f2d6c6a
https://doi.org/10.1055/s-2005-865521
https://doi.org/10.1055/s-2005-865521
Autor:
Tero Kivelä, Wim H. J. Kruit, L.-M. Parvinen, O Kloke, E. Kumpulainen, Seppo Pyrhönen, Johan Hansson, M Hahka-Kemppinen, Martin Gore, Meri-Sisko Vuoristo, Yves Humblet, Stefan Suciu
Publikováno v:
European Journal of Cancer, 39, 1115-1120. Elsevier Ltd.
This EORTC multicentre study analysed the efficacy and tolerability in patients with metastatic uveal melanoma of BOLD chemotherapy in combination with recombinant interferon alpha-2b. The dose of bleomycin was 15 mg on days 2 and 5, of vincristine 1
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a80816c9bad331395fb132415f26cf4c
https://pure.eur.nl/en/publications/659e4325-2ed8-4a5b-906e-1bedfed24ef4
https://pure.eur.nl/en/publications/659e4325-2ed8-4a5b-906e-1bedfed24ef4
Autor:
O, Kloke
Publikováno v:
Zeitschrift fur Gerontologie und Geriatrie. 34(4)
The incidence of lung cancer increases with age, and non-small-cell histotypes account for approximately 85% of lung cancers in patients aged older than 65 years. Results of large multicentric trials provide no evidence that elderly lung cancer patie
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::a16c96fb56383d6ddc40e1799f2d3b6b
https://pubmed.ncbi.nlm.nih.gov/11584712
https://pubmed.ncbi.nlm.nih.gov/11584712